Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Jul 6, 2017
Document Date
Jul 2, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc. – IR Site
Issuer
AGIOS PHARMACEUTICALS INC